Approval Marks Pivotal Expansion of HIV Prevention Options in the United States The U.S. Food and Drug Administration has announced its first approval of a long-acting HIV prevention medication, marking a pivotal expansion of HIV prevention options in the United… Read More ›
A new antibody testing study examining samples originally collected through the National Institutes of Health’s All of Us Research Program found evidence of SARS-CoV-2 infections in five states earlier than had initially been reported. These findings were published in the journal Clinical Infectious Diseases…. Read More ›
Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate… Read More ›
African Americans who smoke appear to have more than twice this risk of developing coronary heart disease compared to those who do not smoke, a new study has found. The findings — the first up-close look at the relationship between smoking and coronary heart disease in this population—also examined the risk for plaque buildup in the arteries of African Americans who smoke. Excessive plaque in the arteries is a known predictor of heart attacks and heart failure.
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who have been prescribed the drug to treat COVID-19. The study, which will be conducted at 17 sites in the continental United States and Puerto Rico, aims to determine how pregnant women metabolize the drug and whether there are any potential side effects.
The US announcement revoking the previous administration’s terrorist designation of Yemen’s Houthi movement, formally known as Ansar Allah, will provide “profound relief” to millions in the country, who depend on international assistance and imports for their survival, the UN Spokesperson said on Saturday.
Methamphetamine overdose deaths surged in an eight-year period in the United States, according to a study that will published today in JAMA Psychiatry.